BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4149623)

  • 1. Withdrawal of maintenance drugs with long-term hospitalized mental patients: a critical review.
    Tobias LL; MacDonald ML
    Psychol Bull; 1974 Feb; 81(2):107-25. PubMed ID: 4149623
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance psychotropic drugs in the presence of active treatment programs. A "triple-blind" withdrawal study with long-term mental patients.
    Paul GL; Tobias LL; Holly BL
    Arch Gen Psychiatry; 1972 Jul; 27(1):106-15. PubMed ID: 4555827
    [No Abstract]   [Full Text] [Related]  

  • 3. [Longitudinal profiles of the effects of psychotropic drugs from clinico-methodological viewpoint].
    Helmchen H; Müller-Oerlinghausen B
    Arzneimittelforschung; 1974 Jul; 24(7):976-80. PubMed ID: 4603668
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of tardive dyskinesia with haloperidol and tetrabenazine.
    Kazamatsuri H; Chien CP; Cole JO
    Am J Psychiatry; 1973 Apr; 130(4):479-83. PubMed ID: 4570750
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
    Gilbert PL; Harris MJ; McAdams LA; Jeste DV
    Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L; Bordeleau JM; Gauthier R; Vulpe M; Lapointe L
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 9. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 10. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia.
    Toru M; Shimazono Y; Miyasaka M; Kokubo T; Mori Y; Nasu T
    J Clin Pharmacol New Drugs; 1972; 12(5):221-9. PubMed ID: 4555882
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment patterns in psychiatry: relationships to symptom features and aging.
    Fracchia J; Sheppard C; Merlis S
    J Am Geriatr Soc; 1973 Mar; 21(3):134-8. PubMed ID: 4144996
    [No Abstract]   [Full Text] [Related]  

  • 13. Psychological effects of single-dose antipsychotic medication.
    Serafetinides EA; Clark ML
    Biol Psychiatry; 1973 Dec; 7(3):263-7. PubMed ID: 4586833
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication.
    Prien RF; Cole JO; Belkin NF
    Br J Psychiatry; 1969 Jun; 115(523):679-86. PubMed ID: 5806858
    [No Abstract]   [Full Text] [Related]  

  • 15. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 17. A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients.
    Small JG; Kellams JJ; Milstein V; Moore J
    Am J Psychiatry; 1975 Dec; 132(12):1315-7. PubMed ID: 1106217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of loxapine succinate in chronic schizophrenia.
    Clark ML; Huber WK; Sullivan J; Wood F; Costiloe JP
    Dis Nerv Syst; 1972 Dec; 33(12):783-91. PubMed ID: 4589978
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroleptics. 8. Clinical methodology.
    Ban TA; Bordeleau JM; Debray HR; Hamilton M; Ito H; Overall JE; Pichot P; Reda G; Tetreault L; Volmat R; Wiart C
    Mod Probl Pharmacopsychiatry; 1970; 5():133-40. PubMed ID: 4949817
    [No Abstract]   [Full Text] [Related]  

  • 20. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.